Prentiss Smith & Co’s Wave Life Sciences WVE Stock Holding History

Prentiss Smith & Co’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-500	Closed	-$25K	–	235
2018 Q3	$25K	Hold	500	–	–	0.01%	155
2018 Q2	$19K	Hold	500	–	–	0.01%	175
2018 Q1	$20K	Hold	500	–	–	0.01%	179
2017 Q4	$18K	Hold	500	–	–	0.01%	193
2017 Q3	$11K	Hold	500	–	–	0.01%	195
2017 Q2	$9K	Hold	500	–	–	﹤0.01%	209
2017 Q1	$14K	Hold	500	–	–	0.01%	181
2016 Q4	$13K	Hold	500	–	–	0.01%	188
2016 Q3	$16K	Hold	500	–	–	0.01%	182
2016 Q2	$10K	Buy	+500	New	+$7.79K	0.01%	206

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Prentiss Smith & Co's WVE Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Wave Life Sciences (WVE) in Q4 2018, closing a stake of 500 shares — an estimated $25K sold.

Prentiss Smith & Co first reported a position in WVE in Q2 2016 and held it in 10 quarters. The position peaked at $25K in Q3 2018. 92 funds tracked by Wall St. Rank hold WVE as of Q4 2018.

Prentiss Smith & Co reported no remaining Wave Life Sciences position as of Q4 2018 after selling out during the quarter.
Prentiss Smith & Co sold 500 Wave Life Sciences shares in Q4 2018, an estimated $25K.
Prentiss Smith & Co first reported a position in Wave Life Sciences in Q2 2016 and held it in 10 quarters.
Prentiss Smith & Co's Wave Life Sciences position peaked at $25K in Q3 2018.
92 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.